Reinventing the antimicrobial pipeline in response to the global crisis of antimicrobial-resistant infections

01 March 2019

F1000 Research
View Journal Article / Working Paper

Claas Kirchhelle and co-authors propose a joint, internationally-funded antimicrobial development institute that would fund permanent staff to take on roles previously assigned to pharmaceutical companies. The concept for antimicrobial development aims to maximise society’s investment, through open science, investment in people, and the sharing of intellectual property while overcoming the continuing issue of economic incentive.